Published in Br J Cancer on July 11, 2005
Online survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancer. PLoS One (2013) 4.31
Dysfunctional homologous recombination mediates genomic instability and progression in myeloma. Blood (2008) 1.76
RI-1: a chemical inhibitor of RAD51 that disrupts homologous recombination in human cells. Nucleic Acids Res (2012) 1.36
DNA double-strand break repair as determinant of cellular radiosensitivity to killing and target in radiation therapy. Front Oncol (2013) 1.30
Use of the Rad51 promoter for targeted anti-cancer therapy. Proc Natl Acad Sci U S A (2008) 1.15
Polymorphisms of homologous recombination genes and clinical outcomes of non-small cell lung cancer patients treated with definitive radiotherapy. PLoS One (2011) 1.06
FoxM1 inhibition sensitizes resistant glioblastoma cells to temozolomide by downregulating the expression of DNA-repair gene Rad51. Clin Cancer Res (2012) 1.05
Overexpression of RAD51 occurs in aggressive prostatic cancer. Histopathology (2009) 1.05
Rad51 inhibition is an effective means of targeting DNA repair in glioma models and CD133+ tumor-derived cells. Neuro Oncol (2011) 1.02
Berberine radiosensitizes human esophageal cancer cells by downregulating homologous recombination repair protein RAD51. PLoS One (2011) 0.97
Rad51 promoter-targeted gene therapy is effective for in vivo visualization and treatment of cancer. Mol Ther (2011) 0.90
Rad51 supports triple negative breast cancer metastasis. Oncotarget (2014) 0.89
Proteasome inhibitors block DNA repair and radiosensitize non-small cell lung cancer. PLoS One (2013) 0.88
A Small-Molecule Inhibitor of RAD51 Reduces Homologous Recombination and Sensitizes Multiple Myeloma Cells to Doxorubicin. Front Oncol (2014) 0.86
Rad51 expression is a useful predictive factor for the efficacy of neoadjuvant chemoradiotherapy in squamous cell carcinoma of the esophagus. Ann Surg Oncol (2013) 0.86
DNA repair targeted therapy: The past or future of cancer treatment? Pharmacol Ther (2016) 0.84
Gene expression profiling reveals activation of the FA/BRCA pathway in advanced squamous cervical cancer with intrinsic resistance and therapy failure. BMC Cancer (2014) 0.83
Contributions of the RAD51 N-terminal domain to BRCA2-RAD51 interaction. Nucleic Acids Res (2013) 0.80
RAD54 family translocases counter genotoxic effects of RAD51 in human tumor cells. Nucleic Acids Res (2015) 0.79
Synthesis, molecular modeling, and biological evaluation of novel RAD51 inhibitors. Eur J Med Chem (2015) 0.79
Rad51 in regulating the radiosensitivity of non-small cell lung cancer with different epidermal growth factor receptor mutation status. Thorac Cancer (2015) 0.78
Regulation of Rad51 promoter. Cell Cycle (2014) 0.78
MET inhibitors in combination with other therapies in non-small cell lung cancer. Transl Lung Cancer Res (2012) 0.78
MicroRNAs Used in Combination with Anti-Cancer Treatments Can Enhance Therapy Efficacy. Mini Rev Med Chem (2015) 0.77
The RAD51-stimulatory compound RS-1 can exploit the RAD51 overexpression that exists in cancer cells and tumors. Cancer Res (2014) 0.77
High RAD54B expression: an independent predictor of postoperative distant recurrence in colorectal cancer patients. Oncotarget (2015) 0.76
Rad51 Expression in Nasopharyngeal Carcinoma and Its Association with Tumor Reduction: A Preliminary Study in Indonesia. Iran J Pathol (2016) 0.75
Treatment Outcome and Prognostic Molecular Markers of Supratentorial Primitive Neuroectodermal Tumors. PLoS One (2016) 0.75
Holliday junction trap shows how cells use recombination and a junction-guardian role of RecQ helicase. Sci Adv (2016) 0.75
Association between Genetic Variants in DNA Double-Strand Break Repair Pathways and Risk of Radiation Therapy-Induced Pneumonitis and Esophagitis in Non-Small Cell Lung Cancer. Cancers (Basel) (2016) 0.75
Rapamycin-induced autophagy sensitizes A549 cells to radiation associated with DNA damage repair inhibition. Thorac Cancer (2016) 0.75
Overexpression of Rad51 Predicts Poor Prognosis in Colorectal Cancer: Our Experience with 54 Patients. PLoS One (2017) 0.75
Expression of PH Domain Leucine-rich Repeat Protein Phosphatase, Forkhead Homeobox Type O 3a and RAD51, and their Relationships with Clinicopathologic Features and Prognosis in Ovarian Serous Adenocarcinoma. Chin Med J (Engl) (2017) 0.75
The purine scaffold Hsp90 inhibitor PU-H71 sensitizes cancer cells to heavy ion radiation by inhibiting DNA repair by homologous recombination and non-homologous end joining. Radiother Oncol (2016) 0.75
(-)-Guaiol regulates RAD51 stability via autophagy to induce cell apoptosis in non-small cell lung cancer. Oncotarget (2016) 0.75
Revisions in the International System for Staging Lung Cancer. Chest (1997) 15.68
Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell (1997) 8.28
Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2. Nature (1997) 8.04
Rad51-deficient vertebrate cells accumulate chromosomal breaks prior to cell death. EMBO J (1998) 6.65
Targeted disruption of the Rad51 gene leads to lethality in embryonic mice. Proc Natl Acad Sci U S A (1996) 6.04
Prognostic factors in non-small cell lung cancer: a decade of progress. Chest (2002) 3.23
Overexpression of Rad51 protein stimulates homologous recombination and increases resistance of mammalian cells to ionizing radiation. Nucleic Acids Res (1998) 2.63
Identification of differentially expressed genes in pancreatic cancer cells using cDNA microarray. Cancer Res (2002) 2.55
p53 is linked directly to homologous recombination processes via RAD51/RecA protein interaction. EMBO J (1996) 2.25
Lung cancer--time to move on from chemotherapy. N Engl J Med (2002) 2.00
Elevated levels of Rad51 recombination protein in tumor cells. Cancer Res (2002) 2.00
Over-expression of wild-type Rad51 correlates with histological grading of invasive ductal breast cancer. Int J Cancer (2000) 1.70
DNA repair and recombination factor Rad51 is over-expressed in human pancreatic adenocarcinoma. Oncogene (2000) 1.56
Elevated recombination in immortal human cells is mediated by HsRAD51 recombinase. Mol Cell Biol (1997) 1.54
Homologous recombination and cell cycle checkpoints: Rad51 in tumour progression and therapy resistance. Toxicology (2003) 1.38
In vitro and in vivo potentiation of radiosensitivity of malignant gliomas by antisense inhibition of the RAD51 gene. Biochem Biophys Res Commun (1998) 1.34
Morphometric grading of invasive ductal breast cancer. I. Thresholds for nuclear grade. Br J Cancer (1998) 1.06
Current concepts in the staging of non-small cell lung cancer. Surg Oncol (2002) 1.05
Prognostic factors in lung cancer: tables and comments. Eur Respir J (1994) 1.00
Increased expression of human DNA repair genes, XRCC1, XRCC3 and RAD51, in radioresistant human KB carcinoma cell line N10. Oral Oncol (1998) 0.97
The World Health Organization's Histological Classification of Lung Tumors: a comparison of the first and second editions. Cancer Detect Prev (1982) 0.89
Isolation and characterization of six monoclonal antibodies raised against human RAD51 recombinant protein. Hybridoma (1996) 0.83
Use of DNA polymerase I primed by a synthetic oligonucleotide to determine a nucleotide sequence in phage fl DNA. Proc Natl Acad Sci U S A (1973) 7.11
High resolution mapping of the binding site on human IgG1 for Fc gamma RI, Fc gamma RII, Fc gamma RIII, and FcRn and design of IgG1 variants with improved binding to the Fc gamma R. J Biol Chem (2000) 5.18
CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway. Oncogene (2007) 3.96
MaxSub: an automated measure for the assessment of protein structure prediction quality. Bioinformatics (2000) 3.86
The RNA-binding protein HF-I, known as a host factor for phage Qbeta RNA replication, is essential for rpoS translation in Escherichia coli. Genes Dev (1996) 3.62
Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients. Kidney Int (2007) 3.34
The response regulator RssB controls stability of the sigma(S) subunit of RNA polymerase in Escherichia coli. EMBO J (1996) 2.91
Osmotic regulation of rpoS-dependent genes in Escherichia coli. J Bacteriol (1993) 2.83
Leptin deficiency produces contrasting phenotypes in bones of the limb and spine. Bone (2004) 2.75
Role for the histone-like protein H-NS in growth phase-dependent and osmotic regulation of sigma S and many sigma S-dependent genes in Escherichia coli. J Bacteriol (1995) 2.55
Identification of transcriptional start sites and the role of ppGpp in the expression of rpoS, the structural gene for the sigma S subunit of RNA polymerase in Escherichia coli. J Bacteriol (1995) 2.54
Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Gastroenterology (1991) 2.43
Identification and molecular analysis of glgS, a novel growth-phase-regulated and rpoS-dependent gene involved in glycogen synthesis in Escherichia coli. Mol Microbiol (1992) 2.39
The heat capacity of proteins. Proteins (1995) 2.37
Reappraisal of the role of axillary lymph node dissection in the conservative treatment of breast cancer. J Clin Oncol (1997) 2.35
Increased incidence of Guillain-Barré syndrome after surgery. Eur J Neurol (2012) 2.32
The RNA-binding protein HF-I plays a global regulatory role which is largely, but not exclusively, due to its role in expression of the sigmaS subunit of RNA polymerase in Escherichia coli. J Bacteriol (1997) 2.31
LAI inversion algorithm based on directional reflectance kernels. J Environ Manage (2006) 2.31
Phosphohexosyl recognition is a general characteristic of pinocytosis of lysosomal glycosidases by human fibroblasts. J Clin Invest (1977) 2.18
Preclinical studies to predict the disposition of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand in humans: characterization of in vivo efficacy, pharmacokinetics, and safety. J Pharmacol Exp Ther (2001) 2.13
The role of chest and abdominal computed tomography in assessing the severity of acute corrosive ingestion. Clin Toxicol (Phila) (2013) 2.06
Oral topical decontamination for preventing ventilator-associated pneumonia: a systematic review and meta-analysis of randomized controlled trials. J Hosp Infect (2013) 2.05
Mutation incidence and coincidence in non small-cell lung cancer: meta-analyses by ethnicity and histology (mutMap). Ann Oncol (2013) 2.04
Structure prediction meta server. Bioinformatics (2001) 2.02
3' End-group labeling and partial sequence determination of oligodeoxynucleotides. Methods Enzymol (1974) 2.00
Estimation of changes in side chain configurational entropy in binding and folding: general methods and application to helix formation. Proteins (1994) 1.97
Vertebral artery dissection and cerebellar infarction following chiropractic manipulation. Emerg Med J (2006) 1.92
A new method for the sequence analysis of oligodeoxynucleotides. Biochem Biophys Res Commun (1971) 1.89
A computer vision based technique for 3-D sequence-independent structural comparison of proteins. Protein Eng (1993) 1.83
LiveBench-1: continuous benchmarking of protein structure prediction servers. Protein Sci (2001) 1.80
Coi1-dependent expression of an Arabidopsis vegetative storage protein in flowers and siliques and in response to coronatine or methyl jasmonate. Plant Physiol (1995) 1.77
A study of quality measures for protein threading models. BMC Bioinformatics (2001) 1.74
Regulation of RssB-dependent proteolysis in Escherichia coli: a role for acetyl phosphate in a response regulator-controlled process. Mol Microbiol (1998) 1.74
LiveBench-2: large-scale automated evaluation of protein structure prediction servers. Proteins (2001) 1.68
Phosphorylation of serine 392 stabilizes the tetramer formation of tumor suppressor protein p53. Biochemistry (1997) 1.66
High-pathogenicity island of Yersinia pestis in enterobacteriaceae isolated from blood cultures and urine samples: prevalence and functional expression. J Infect Dis (2000) 1.66
Myocardial contrast echocardiography can be used to quantify intramyocardial blood volume: new insights into structural mechanisms of coronary autoregulation. Circulation (1997) 1.63
Structural energetics of peptide recognition: angiotensin II/antibody binding. Proteins (1993) 1.58
EZH2 supports nasopharyngeal carcinoma cell aggressiveness by forming a co-repressor complex with HDAC1/HDAC2 and Snail to inhibit E-cadherin. Oncogene (2011) 1.56
A role for adenosine deaminase in human monocyte maturation. J Clin Invest (1976) 1.55
Surface-modified biodegradable albumin nano- and microspheres. II: effect of surface charges on in vitro phagocytosis and biodistribution in rats. Eur J Pharm Biopharm (1998) 1.54
Overexpression of matrix metalloproteinase 10 is associated with poor survival in patients with early stage of esophageal squamous cell carcinoma. Dis Esophagus (2011) 1.54
UDP-glucose is a potential intracellular signal molecule in the control of expression of sigma S and sigma S-dependent genes in Escherichia coli. J Bacteriol (1995) 1.52
Mitomycin C as an adjunct to postoperative radiation therapy in squamous cell carcinoma of the head and neck: results from two randomized clinical trials. Int J Radiat Oncol Biol Phys (1993) 1.52
Anaphylactoid reactions, LDL apheresis with dextran sulphate, and ACE inhibitors. Lancet (1992) 1.52
Cotton-wool spots. Retina (1986) 1.45
Clusterin plays an important role in hepatocellular carcinoma metastasis. Oncogene (2006) 1.45
Coronary collateral development during chronic ischemia: serial assessment using harmonic myocardial contrast echocardiography. J Am Coll Cardiol (2000) 1.44
Ipsilateral breast tumor recurrence as a predictor of distant disease: implications for systemic therapy at the time of local relapse. J Clin Oncol (1996) 1.44
[Neuroprotection and regeneration after traumatic lesion of the optic nerve]. Klin Monbl Augenheilkd (2004) 1.40
[Idiopathic portal hypertension associated with connective tissue disease similar to systemic lupus erythematosus]. Gastroenterol Clin Biol (1989) 1.39
Entropy in biological binding processes: estimation of translational entropy loss. Proteins (1994) 1.39
Treatment of male infertility: the ICSI revolution is secure. N Z Med J (1996) 1.38
Determination of a nucleotide sequence in bacteriophage f1 DNA by primed synthesis with DNA polymerase. J Mol Biol (1974) 1.32
Wireless capsule video endoscopy compared to barium follow-through and computerised tomography in patients with suspected Crohn's disease--final report. Dig Liver Dis (2004) 1.32
Molecular basis of co-operativity in protein folding. III. Structural identification of cooperative folding units and folding intermediates. J Mol Biol (1992) 1.29
Cyr61, a member of CCN family, is a tumor suppressor in non-small cell lung cancer. J Biol Chem (2001) 1.28
Characterisation of the promoter region of the human DNA-repair gene Rad51. Eur J Gynaecol Oncol (2005) 1.27
Prognosis following local recurrence in the conservatively treated breast cancer patient. Int J Radiat Oncol Biol Phys (1991) 1.26
Scapuloperoneal syndrome type Kaeser and a wide phenotypic spectrum of adult-onset, dominant myopathies are associated with the desmin mutation R350P. Brain (2007) 1.26
Involvement of Cyr61 in growth, migration, and metastasis of prostate cancer cells. Br J Cancer (2008) 1.24
Survival benefit with erlotinib maintenance therapy in patients with advanced non-small-cell lung cancer (NSCLC) according to response to first-line chemotherapy. Ann Oncol (2011) 1.24
FKRP (826C>A) frequently causes limb-girdle muscular dystrophy in German patients. J Med Genet (2004) 1.24
Molecular surface representations by sparse critical points. Proteins (1994) 1.23
A dynein mutation attenuates motor neuron degeneration in SOD1(G93A) mice. Exp Neurol (2006) 1.23
Treatment of retinal detachment with congenital optic pit by krypton laser photocoagulation. Graefes Arch Clin Exp Ophthalmol (1987) 1.23
Follow-up recommendations for patients with American Joint Committee on Cancer Stages I-III malignant melanoma. Cancer (1999) 1.22
Hypoxia-inducible factor-1alpha-induced differentiation of myeloid leukemic cells is its transcriptional activity independent. Oncogene (2007) 1.22
Misleading positioning of a Foley catheter balloon. Br J Radiol (2006) 1.21
Correlation of structural features of phosphomannans with their ability to inhibit pinocytosis of human beta-glucuronidase by human fibroblasts. J Biol Chem (1978) 1.21
Norfloxacin primary prophylaxis of bacterial infections in cirrhotic patients with ascites: a double-blind randomized trial. J Hepatol (1998) 1.20
Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy. Basic Res Cardiol (2013) 1.20
Azimuthal anisotropy of charged particles at high transverse momenta in Pb-Pb collisions at sqrt[s(NN)] = 2.76 TeV. Phys Rev Lett (2012) 1.19
Tenascin-C hexabrachion assembly is a sequential two-step process initiated by coiled-coil alpha-helices. J Biol Chem (1998) 1.18
The primary structure of the human ribosomal protein S6 derived from a cloned cDNA. J Biol Chem (1988) 1.16
DLK1: increased expression in gliomas and associated with oncogenic activities. Oncogene (2006) 1.15
Analysis of topological and nontopological structural similarities in the PDB: new examples with old structures. Proteins (1996) 1.14
Body mass index and injury risk among US children 9-15 years old in motor vehicle crashes. Inj Prev (2008) 1.10
MTSS1, a novel target of DNA methyltransferase 3B, functions as a tumor suppressor in hepatocellular carcinoma. Oncogene (2011) 1.10
Subtle shifts in the ratio between pro- and antiapoptotic molecules after activation of corticosteroid receptors decide neuronal fate. FASEB J (2000) 1.09
Inter- and intra-subject variability in gabapentin absorption and absolute bioavailability. Epilepsy Res (2000) 1.09
Search for new physics with same-sign isolated dilepton events with jets and missing transverse energy. Phys Rev Lett (2012) 1.09
Analysis of the interaction between the HIV-inactivating protein cyanovirin-N and soluble forms of the envelope glycoproteins gp120 and gp41. Mol Pharmacol (2000) 1.09
Characterization of the integration site of Yersinia high-pathogenicity island in Escherichia coli. FEMS Microbiol Lett (1999) 1.09
Downregulation of organic anion transporters OAT1 and OAT3 correlates with impaired secretion of para-aminohippurate after ischemic acute renal failure in rats. Am J Physiol Renal Physiol (2007) 1.08
Characterisation of a novel cell line (CSQT-2) with high metastatic activity derived from portal vein tumour thrombus of hepatocellular carcinoma. Br J Cancer (2010) 1.07
Interleukin-6 contributes to CNS axon regeneration upon inflammatory stimulation. Cell Death Dis (2013) 1.06
Pretreatment prognostic factors in carcinoma of the uterine cervix: a multivariable analysis of the effect of age, stage, histology and blood counts on survival. Int J Radiat Oncol Biol Phys (1983) 1.06
Unilateral optic nerve crush induces bilateral retinal glial cell proliferation. Eur J Neurosci (2005) 1.06
Genetic structure of a foundation species: scaling community phenotypes from the individual to the region. Heredity (Edinb) (2006) 1.05
High-throughput generation and engineering of recombinant human antibodies. J Immunol Methods (2001) 1.05
Ferric enterochelin transport in Yersinia enterocolitica: molecular and evolutionary aspects. J Bacteriol (1999) 1.05
Gender differences in ethanol preference and ingestion in rats. The role of the gonadal steroid environment. J Clin Invest (1998) 1.05
The giant linear plasmid pHG207 from Rhodococcus sp. encoding hydrogen autotrophy: characterization of the plasmid and its termini. J Gen Microbiol (1993) 1.04
Multiple myeloma involving the iris. Arch Ophthalmol (1988) 1.04
Activity and expression of the 20S proteasome are increased in skeletal muscle during sepsis. Am J Physiol (1999) 1.04
Sulfotransferase 1A1 polymorphism, endogenous estrogen exposure, well-done meat intake, and breast cancer risk. Cancer Epidemiol Biomarkers Prev (2001) 1.03